These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. miR-185 targets RhoA and Cdc42 expression and inhibits the proliferation potential of human colorectal cells. Liu M, Lang N, Chen X, Tang Q, Liu S, Huang J, Zheng Y, Bi F. Cancer Lett; 2011 Feb 28; 301(2):151-60. PubMed ID: 21186079 [Abstract] [Full Text] [Related]
24. CHIP/Stub1 functions as a tumor suppressor and represses NF-κB-mediated signaling in colorectal cancer. Wang Y, Ren F, Wang Y, Feng Y, Wang D, Jia B, Qiu Y, Wang S, Yu J, Sung JJ, Xu J, Zeps N, Chang Z. Carcinogenesis; 2014 May 28; 35(5):983-91. PubMed ID: 24302614 [Abstract] [Full Text] [Related]
27. miRNA-99b-5p suppresses liver metastasis of colorectal cancer by down-regulating mTOR. Li W, Chang J, Wang S, Liu X, Peng J, Huang D, Sun M, Chen Z, Zhang W, Guo W, Li J. Oncotarget; 2015 Sep 15; 6(27):24448-62. PubMed ID: 26259252 [Abstract] [Full Text] [Related]
28. Promotion of colorectal cancer growth and metastasis by the LIM and SH3 domain protein 1. Zhao L, Wang H, Liu C, Liu Y, Wang X, Wang S, Sun X, Li J, Deng Y, Jiang Y, Ding Y. Gut; 2010 Sep 15; 59(9):1226-35. PubMed ID: 20660701 [Abstract] [Full Text] [Related]
29. The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling. Han P, Li JW, Zhang BM, Lv JC, Li YM, Gu XY, Yu ZW, Jia YH, Bai XF, Li L, Liu YL, Cui BB. Mol Cancer; 2017 Jan 13; 16(1):9. PubMed ID: 28086904 [Abstract] [Full Text] [Related]
32. USP11 promotes growth and metastasis of colorectal cancer via PPP1CA-mediated activation of ERK/MAPK signaling pathway. Sun H, Ou B, Zhao S, Liu X, Song L, Liu X, Wang R, Peng Z. EBioMedicine; 2019 Oct 13; 48():236-247. PubMed ID: 31521612 [Abstract] [Full Text] [Related]
33. ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis. Agesen TH, Sveen A, Merok MA, Lind GE, Nesbakken A, Skotheim RI, Lothe RA. Gut; 2012 Nov 13; 61(11):1560-7. PubMed ID: 22213796 [Abstract] [Full Text] [Related]
35. A transcribed ultraconserved noncoding RNA, uc.285+, promotes colorectal cancer proliferation through dual targeting of CDC42 by directly binding mRNA and protein. Chen S, Zhao Q, Zhang R, Liu J, Peng W, Xu H, Li X, Wang X, Wu S, Li G, Nan A. Transl Res; 2024 Aug 13; 270():52-65. PubMed ID: 38552953 [Abstract] [Full Text] [Related]
37. The clinical significance of forkhead box protein A1 and its role in colorectal cancer. Ma W, Jiang J, Li M, Wang H, Zhang H, He X, Huang L, Zhou Q. Mol Med Rep; 2016 Sep 13; 14(3):2625-31. PubMed ID: 27484093 [Abstract] [Full Text] [Related]
38. Long noncoding RNA GAPLINC promotes invasion in colorectal cancer by targeting SNAI2 through binding with PSF and NONO. Yang P, Chen T, Xu Z, Zhu H, Wang J, He Z. Oncotarget; 2016 Jul 05; 7(27):42183-42194. PubMed ID: 27259250 [Abstract] [Full Text] [Related]
39. IPO5 promotes the proliferation and tumourigenicity of colorectal cancer cells by mediating RASAL2 nuclear transportation. Zhang W, Lu Y, Li X, Zhang J, Lin W, Zhang W, Zheng L, Li X. J Exp Clin Cancer Res; 2019 Jul 09; 38(1):296. PubMed ID: 31288861 [Abstract] [Full Text] [Related]